Literature DB >> 22125656

Synergy and its clinical reievance in topical acne therapy.

Leon H Kircik1.   

Abstract

Biologically active agents generally are thought of either as acting synergistically (they work together) or antagonistically (they counteract each other). However, the notion of synergy has a more nuanced meaning in pharmacological discussions. Two agents may complement each other, usually by providing a cumulative or additive effect. Within pharmacological discourse, "synergy" indicates that the sum of two agents' combined action is greater than the sum of the efficacy of the constituent parts. An example of synergy in dermatological therapy is a novel fixed combination formulation of adapalene 0.1% and benzoyl peroxide 2.5%. While the use of both topical benzoyl peroxide and a retinoid for the management of mild-to-moderate acne vulgaris has become the standard of care, data show that the two agents in the once-daily, fixed combination adapalene/benzoyl peroxide gel formulation confer a synergistic effect, suggesting that the formulation can enhance efficacy and improve patient convenience and adherence.

Entities:  

Year:  2011        PMID: 22125656      PMCID: PMC3225138     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  16 in total

Review 1.  New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group.

Authors:  Diane Thiboutot; Harald Gollnick; Vincenzo Bettoli; Brigitte Dréno; Sewon Kang; James J Leyden; Alan R Shalita; Vicente Torres Lozada; Diane Berson; Andrew Finlay; Chee Leok Goh; María Isabel Herane; Ana Kaminsky; Raj Kubba; Alison Layton; Yoshiki Miyachi; Montserrat Perez; Jaime Piquero Martin; Marcia Ramos-E-Silva; Jo Ann See; Neil Shear; John Wolf
Journal:  J Am Acad Dermatol       Date:  2009-05       Impact factor: 11.527

2.  Effective and safe combination therapy for severe acne vulgaris: a randomized, vehicle-controlled, double-blind study of adapalene 0.1%-benzoyl peroxide 2.5% fixed-dose combination gel with doxycycline hyclate 100 mg.

Authors:  Linda Stein Gold; Alma Cruz; Lawrence Eichenfield; Jerry Tan; Joseph Jorizzo; Nabil Kerrouche; Jean-Charles Dhuin
Journal:  Cutis       Date:  2010-02

Review 3.  The integral role of topical and oral retinoids in the early treatment of acne.

Authors:  A Shalita
Journal:  J Eur Acad Dermatol Venereol       Date:  2001       Impact factor: 6.166

4.  Trends in the treatment of acne vulgaris: are measures being taken to avoid antimicrobial resistance?

Authors:  Megan A Kinney; Brad A Yentzer; Alan B Fleischer; Steven R Feldman
Journal:  J Drugs Dermatol       Date:  2010-05       Impact factor: 2.114

5.  'Keratolytic' properties of benzoyl peroxide and retinoic acid resemble salicylic acid in man.

Authors:  J M Waller; F Dreher; S Behnam; C Ford; C Lee; T Tiet; G D Weinstein; H I Maibach
Journal:  Skin Pharmacol Physiol       Date:  2006-06-16       Impact factor: 3.479

6.  Synergistic efficacy of adapalene 0.1%-benzoyl peroxide 2.5% in the treatment of 3855 acne vulgaris patients.

Authors:  Jerry Tan; Harald P M Gollnick; Christian Loesche; Y May Ma; Linda Stein Gold
Journal:  J Dermatolog Treat       Date:  2010-07-28       Impact factor: 3.359

7.  Prescribing patterns for topical retinoids: analyses of 15 years of data from the national ambulatory medical care survey.

Authors:  Rajesh Balkrishnan; Monali J Bhosle; Fabian Camacho; Alan B Fleischer; Steven R Feldman
Journal:  J Dermatolog Treat       Date:  2010-05       Impact factor: 3.359

8.  Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled study.

Authors:  Diane M Thiboutot; Jonathan Weiss; Alicia Bucko; Lawrence Eichenfield; Terry Jones; Scott Clark; Yin Liu; Michael Graeber; Sewon Kang
Journal:  J Am Acad Dermatol       Date:  2007-07-26       Impact factor: 11.527

9.  A North American study of adapalene-benzoyl peroxide combination gel in the treatment of acne.

Authors:  Linda Stein Gold; Jerry Tan; Alma Cruz-Santana; Kim Papp; Yves Poulin; Joel Schlessinger; Judi Gidner; Yin Liu; Michael Graeber
Journal:  Cutis       Date:  2009-08

10.  Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients.

Authors:  H P M Gollnick; Z Draelos; M J Glenn; L A Rosoph; A Kaszuba; R Cornelison; B Gore; Y Liu; M Graeber
Journal:  Br J Dermatol       Date:  2009-05-21       Impact factor: 9.302

View more
  4 in total

1.  Multicenter study for efficacy and safety evaluation of a fixeddose combination gel with adapalen 0.1% and benzoyl peroxide 2.5% (Epiduo® for the treatment of acne vulgaris in Brazilian population.

Authors:  José Alexandre de Souza Sittart; Adilson da Costa; Fabiane Mulinari-Brenner; Ivonise Follador; Luna Azulay-Abulafia; Lia Cândida Miranda de Castro
Journal:  An Bras Dermatol       Date:  2015-12       Impact factor: 1.896

2.  Development and Sequential Analysis of a New Multi-Agent, Anti-Acne Formulation Based on Plant-Derived Antimicrobial and Anti-Inflammatory Compounds.

Authors:  Crina Saviuc; Bianca Ciubucă; Gabriela Dincă; Coralia Bleotu; Veronica Drumea; Mariana-Carmen Chifiriuc; Marcela Popa; Gratiela Gradisteanu Pircalabioru; Luminita Marutescu; Veronica Lazăr
Journal:  Int J Mol Sci       Date:  2017-01-17       Impact factor: 5.923

Review 3.  Why Topical Retinoids Are Mainstay of Therapy for Acne.

Authors:  James Leyden; Linda Stein-Gold; Jonathan Weiss
Journal:  Dermatol Ther (Heidelb)       Date:  2017-06-05

4.  Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug.

Authors:  Linda Stein Gold; Hilary Baldwin; Leon H Kircik; Jonathan S Weiss; David M Pariser; Valerie Callender; Edward Lain; Michael Gold; Kenneth Beer; Zoe Draelos; Neil Sadick; Radhakrishnan Pillai; Varsha Bhatt; Emil A Tanghetti
Journal:  Am J Clin Dermatol       Date:  2021-10-21       Impact factor: 7.403

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.